Home

IOC — Deck

Indian Oil Corporation · IOC · NSE

India's largest oil refiner and fuel retailer, controlled by the Government of India (51.5%) — processes about a third of the country's crude through 11 refineries and sells fuel via 41,000 retail outlets plus 12,900 LPG distributors.

$1.51
Share price
$21B
Market cap
$82B
Revenue (TTM)
80.8 MMTPA
Refining capacity ~32% of India's total
Listed since 1959; the post-bonus-adjusted price has spent a decade inside a $0.79–$2.28 corridor (at then-current rates) — touched $1.06 at the COVID trough, hit $2.28 in early 2024, sits at $1.51 today.
2 · The tension

A twelve-year ROCE gap to BPCL gets its verdict in 120 days.

  • Cyclical. IOC ROCE 7.4% vs BPCL 16.2% in FY25 — but TTM PAT $3.9B already prints 167% above the trough, and Q2 FY26 integrated margin hit a two-year $12.6/bbl high.
  • Structural. IOC has banded inside a 4–7× P/E for twelve consecutive years across every prior capex cycle. Consolidated capital tripled. Through-cycle returns never converged with BPCL.
  • The arithmetic. Three brownfield expansions — Panipat (90% physical progress), Gujarat (84%), Barauni (88%) — commission Jun–Aug 2026, adding 17 MMTPA at 15–18% pre-tax brownfield economics onto a base earning 7%.
Walks blended ROCE toward 12–15% within two years of full ramp — if it survives the LPG and pump-price drag that crushed it in FY23 and FY25.
3 · The 120-day stack

A typical IOC catalyst tab says 'wait for the AR.' This one says don't.

  • ~21 May 2026 — Q4 FY26 print. First quarter to recognise ~$386M of the $1.5B LPG compensation, integrated-margin follow-through on the Q2 FY26 high, and the first dated commissioning update with Panipat & Gujarat under 60 days from go-live.
  • Jun 2026 — Panipat 15→25 MMTPA + Gujarat 13.7→18 MMTPA. The two largest brownfields commission in the same month; the Mundra–Panipat crude pipeline goes live alongside.
  • Aug 2026 — Barauni 6→9 MMTPA + Q1 FY27 print + FY26 Annual Report. First quarter on an enlarged ~92 MMTPA base; the AR also reveals next CARO ix(d) print and the long-overdue Albemarle FCPA review status.
Six high-impact events inside one fiscal half. The verdict here arrives — it does not wait.
4 · Where we disagree

LPG quietly became a calendarized sovereign receivable. Consensus still calls it a drag.

  • Two bailouts in three years. $2.7B (FY23) + $3.4B (Aug 2025) cumulative, plus $1.5B to IOC paid in twelve fixed monthly tranches of $129M through Oct 2026. Six tranches have already landed on schedule.
  • Consensus still treats it as one-off. HDFC, MOFSL, ICICI all model LPG comp as discretionary non-operating income; broker target spread runs $1.60–$2.08 because no one has rebuilt the framework around the codified mechanism.
  • The reframe. On the cash basis, the ~$1.6–2.1B/yr drag becomes a working-capital lag, not a permanent hole — the BPCL ROCE gap shrinks 300–400 bps mechanically and 1.3× book × $1.49 = $1.94 (28% upside) before brownfields are priced in.
Watch the next six monthly tranches. One missed payment and the framework reading collapses back into consensus.
5 · The money picture

Trough year prints, then a single quarter nearly matches it.

$3.9B
TTM net income +167% vs FY25 trough
$1.3B
Q3 FY26 PAT alone 4× YoY — concall cancelled
0.65×
5y FCF / Net income debt grew $4.4B to fund payout
4.9%
Dividend yield at 1.0× book

Earnings collapsed 67% from $4.8B (FY24) to $1.5B (FY25) on crude volatility and frozen pump prices, then recovered violently — Q3 FY26 alone ($1.3B) nearly matched the entire prior fiscal year. The catch: capex has run 1.7–2.1× depreciation for nine straight years, FCF turns negative in every soft-margin year, and the $4.4B of incremental debt over FY21–FY25 mechanically equals the gap between FCF and the dividend. The payout has been part-funded by lenders, not the business.

6 · The governance overhang

A C- governance grade and a forensic Watch flag the multiple already prices in.

  • Five-plus consecutive quarters of NSE/BSE fines for unfilled independent director seats; the audit committee ran four months of FY25 with one independent director; zero women independent directors for three years running.
  • CARO ix(d) qualification. $7.2B of short-term funds funding long-term assets (40% of total debt), and the mismatch grew $1.5B in FY25 alone. Auditor language amounts to revolving paper.
  • Open Albemarle FCPA review. The 2009–2011 catalyst-bribery matter that named 'two former senior IOC officials' has been under internal review for over twelve months — and is not in the FY25 Directors' Report.
Skin-in-the-game scored 2/10. Eight whole-time directors collectively own ~$60K of stock — less than one director's annual salary.
7 · Bull and Bear

Lean cautious — the twelve-year structural anchor outweighs the visible capex wave.

  • For. TTM PAT $3.9B is 167% above the FY25 trough; Q2 FY26 integrated GRM hit a two-year $12.6/bbl high; 1.0× book + 4.9% yield bound the downside.
  • For. Three brownfields at 84–90% physical progress commission Jun–Aug 2026; brownfield economics of 15–18% pre-tax ROCE onto a base earning 7% is mechanical re-rating fuel.
  • Against. IOC has banded inside 4–7× P/E for twelve years across every prior capex cycle; the BPCL ROCE gap (7.4% vs 16.2%) has held even as capital employed tripled.
  • Against. CARO ix(d) ST→LT mismatch grew $1.5B in FY25 alone; 5 of 14 quantified management promises have already slipped — Paradip Petchem +2 years, petchem intensity 6% versus the 7%-by-2025 commitment.
Bull target $2.03 (8.5× through-cycle EPS $0.23). Bear $1.07 (8× EPS $0.14). Flips to Lean Long if Q4 FY26 PAT >$0.85B and CARO ix(d) shrinks below $5.3B at the FY26 sign-off.

Watchlist to re-rate: (1) Q4 FY26 print on ~21 May 2026 — does management host the call this time? (2) Panipat & Gujarat commissioning announcements in June; (3) CARO ix(d) print and Albemarle disclosure in the ~Aug 2026 Annual Report.